Ockham has received CEO Cancer Gold Standard™ accreditation, recognizing the commitment of the oncology-focused contract research organization (CRO) to reducing cancer risk by promoting healthy lifestyle choices, encouraging early detection through cancer screenings, and ensuring access to quality treatment for their own employees and their covered family members.
Christopher A. Viehbacher chairs the CEO Roundtable on Cancer, a nonprofit organization of cancer-fighting CEOs who created the CEO Cancer Gold Standard™, in collaboration with the National Cancer Institute, many of its designated cancer centers, and leading health non-profit organizations and professionals. Today, more than 2.5 million employees and family members are benefiting from the vision and leadership of employers like Ockham.
“CEO Cancer Gold Standard accreditation is further testament that Ockham’s cancer fighting efforts begin with improving the health of their own employees,” said Christopher A. Viehbacher, CEO of Sanofi.
The CEO Cancer Gold Standard™ calls for companies to evaluate their health benefits and corporate culture and take extensive, concrete actions in five key areas of health and wellness to fight cancer in the workplace. To earn Gold Standard accreditation, a company must establish programs to reduce cancer risk by discouraging tobacco use; encouraging physical activity; promoting healthy nutrition; detecting cancer at its earliest stages; and providing access to quality care, including participation in clinical trials.